AUD 0.2
(-9.09%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 4.89 Million AUD | 128.77% |
2023 | 2.13 Million AUD | -8.67% |
2022 | 2.34 Million AUD | -15.37% |
2021 | 2.76 Million AUD | 4.35% |
2020 | 2.65 Million AUD | 20216.14% |
2019 | 13.04 Thousand AUD | -99.66% |
2018 | 3.82 Million AUD | 26.54% |
2017 | 3.02 Million AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | 1.44 Million AUD | 0.0% |
2024 FY | -1.79 Million AUD | -184.1% |
2024 Q1 | 1 Million AUD | -85.23% |
2024 Q2 | -1.15 Million AUD | -214.7% |
2024 Q3 | 1.44 Million AUD | 225.28% |
2023 Q1 | 409 Thousand AUD | -90.76% |
2023 FY | 2.13 Million AUD | -8.67% |
2023 Q4 | 6.79 Million AUD | 929.39% |
2023 Q3 | 660 Thousand AUD | -88.34% |
2023 Q2 | 5.65 Million AUD | 1283.62% |
2022 Q2 | 3.74 Million AUD | 1998.21% |
2022 Q1 | 178.5 Thousand AUD | -94.19% |
2022 FY | 2.34 Million AUD | -15.37% |
2022 Q4 | 4.42 Million AUD | 1683.97% |
2022 Q3 | -279.5 Thousand AUD | -107.46% |
2021 Q1 | 639.03 Thousand AUD | -65.02% |
2021 Q2 | 2.5 Million AUD | 291.77% |
2021 Q3 | 743.96 Thousand AUD | -70.28% |
2021 Q4 | 3.07 Million AUD | 312.99% |
2021 FY | 2.76 Million AUD | 4.35% |
2020 FY | 2.65 Million AUD | 20216.14% |
2020 Q4 | 1.82 Million AUD | 156.57% |
2020 Q3 | 712.04 Thousand AUD | -54.38% |
2020 Q2 | 1.56 Million AUD | 154.47% |
2020 Q1 | 613.37 Thousand AUD | 251.82% |
2019 Q1 | -20.6 Thousand AUD | -103.16% |
2019 FY | 13.04 Thousand AUD | -99.66% |
2019 Q3 | 27.13 Thousand AUD | 231.67% |
2019 Q2 | -20.6 Thousand AUD | 0.0% |
2019 Q4 | 174.34 Thousand AUD | 542.63% |
2018 Q4 | 651.5 Thousand AUD | 0.0% |
2018 Q1 | 759 Thousand AUD | 0.0% |
2018 Q2 | 759 Thousand AUD | 0.0% |
2018 Q3 | 651.5 Thousand AUD | -14.16% |
2018 FY | 3.82 Million AUD | 26.54% |
2017 FY | 3.02 Million AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alcidion Group Limited | 31.92 Million AUD | 84.677% |
Artrya Limited | -13.24 Million AUD | 136.924% |
Cogstate Limited | 37.59 Million AUD | 86.991% |
Careteq Limited | 6.74 Million AUD | 27.481% |
Doctor Care Anywhere Group PLC | 28.65 Million AUD | 82.932% |
Emyria Limited | -167.54 Thousand AUD | 3019.163% |
Global Health Limited | -689.94 Thousand AUD | 808.901% |
HITIQ Limited | 334.63 Thousand AUD | -1361.592% |
Intelicare Holdings Limited | -1.78 Million AUD | 373.62% |
ImExHS Limited | 7.87 Million AUD | 37.859% |
Mach7 Technologies Limited | 5.46 Million AUD | 10.443% |
MedAdvisor Limited | 74.24 Million AUD | 93.413% |
Oakridge International Limited | 481.72 Thousand AUD | -915.301% |
Opyl Limited | -1.86 Million AUD | 362.368% |
PainChek Limited | 726.65 Thousand AUD | -573.081% |
Pro Medicus Limited | 122.3 Million AUD | 96.001% |
Resonance Health Limited | 8.58 Million AUD | 43.058% |
Singular Health Group Ltd | -2.67 Million AUD | 283.025% |
Total Brain Limited | 7.64 Million AUD | 36.058% |